PMID- 9886550 OWN - NLM STAT- MEDLINE DCOM- 19990512 LR - 20190512 IS - 0268-1161 (Print) IS - 0268-1161 (Linking) VI - 13 IP - 12 DP - 1998 Dec TI - Cytokine secretion by human fetal membranes, decidua and placenta at term. PG - 3560-5 AB - Cytokines such as monocyte chemotactic peptide-1 (MCP-1), interleukin-8 (IL-8), RANTES (Regulated on Activation and Normally T-cells Expressed and presumably Secreted) and interleukin-10 (IL-10) are thought to play pivotal roles in immune recognition, acceptance of the fetal allograft, maintenance of pregnancy and parturition. Their secretion and regulation within the third trimester uterus is, however, less well defined. We therefore investigated the release of these cytokines by third trimester amnion, chorion, placenta and decidua, and studied the influence of prostaglandin E2 (PGE2) infusion on their release in a dynamic placental cotyledon perfusion system. MCP-1 was released predominately by the chorion (78.2 +/- 7.3 pg/mg wet tissue weight; mean +/- SEM), decidua (112.4 +/- 5.2 pg/mg) and placenta (101.8 +/- 5.0 pg/mg) with low amounts from the amnion (1.3 +/- 0.4 pg/mg). High concentrations of IL-8 were released by the amnion (39.9 +/- 5.3 pg/mg), chorion (52.8 +/- 1.9 pg/mg), decidua (42.2 +/- 1.5 pg/mg) and placenta (45 +/- 1.3 pg/mg). Release of RANTES was not detectable from the amnion but was detected in moderate amounts from the chorion (6.0 +/- 1.2 pg/mg), decidua (15.2 +/- 1.4 pg/mg) and placenta (26.9 +/- 1.6 pg/mg). Low concentrations of IL-10 were secreted by the chorion (6.8 +/- 0.8 pg/mg), decidua (9.0 +/- 0.9 pg/mg) and placenta (3.3 +/- 0.3 pg/mg) with none detectable from the amnion. MCP-1, IL-8, RANTES and IL-10 were all released by perfused placental cotyledons. PGE2 stimulated release of MCP-1, IL-8 and IL-10 into the maternal and of MCP-1 and IL-8 into the fetal circulation of the placenta but had no effect on RANTES release. It is suggested that MCP-1 and IL-8 may be involved in the inflammatory process of parturition and IL-10 in the protection of the fetal allograft. In addition, PGE2 may have an important immunomodulatory role within the uterus at term. FAU - Denison, F C AU - Denison FC AD - Department of Obstetrics and Gynaecology, University of Edinburgh, Centre for Reproductive Biology, UK. FAU - Kelly, R W AU - Kelly RW FAU - Calder, A A AU - Calder AA FAU - Riley, S C AU - Riley SC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Hum Reprod JT - Human reproduction (Oxford, England) JID - 8701199 RN - 0 (Cytokines) RN - K7Q1JQR04M (Dinoprostone) SB - IM MH - Culture Techniques MH - Cytokines/*metabolism MH - Decidua/*metabolism MH - Dinoprostone/pharmacology MH - Enzyme-Linked Immunosorbent Assay MH - Extraembryonic Membranes/*metabolism MH - Female MH - Humans MH - Placenta/*metabolism MH - Pregnancy MH - *Pregnancy Trimester, Third EDAT- 1999/01/14 00:00 MHDA- 1999/01/14 00:01 CRDT- 1999/01/14 00:00 PHST- 1999/01/14 00:00 [pubmed] PHST- 1999/01/14 00:01 [medline] PHST- 1999/01/14 00:00 [entrez] AID - 10.1093/humrep/13.12.3560 [doi] PST - ppublish SO - Hum Reprod. 1998 Dec;13(12):3560-5. doi: 10.1093/humrep/13.12.3560.